Clinical Trial

KORU Medical Systems Announces Fourth Quarter and Full Year 2024 Financial Results With Record Revenues and Gross Profit; Issues Full Year 2025 Guidance

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on…

10 months ago

The ADDF’s Diagnostics Accelerator Authors New Paper on Ocular Biomarker Landscape, Highlighting Ocular Tests as a Tool for Early Detection of Alzheimer’s Disease

New findings published in Alzheimer's & Dementia suggest blood biomarkers are expected to become the standard method for diagnosing Alzheimer's,…

10 months ago

NanoVibronix Announces Reverse Stock Split

Common Stock Will Begin Trading on Split-Adjusted Basis on March 14, 2025 TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or…

10 months ago

InTandem Capital Partners Announces Strategic Investment in Clinilabs

NEW YORK--(BUSINESS WIRE)--InTandem Capital Partners (“InTandem Capital” or the “Firm”), a healthcare services-focused private equity firm, announced today that it…

10 months ago

Zero Candida Commences Trading on OTCQB Market

VANCOUVER, BC, March 12, 2025 /PRNewswire/ -- Zero Candida Technologies, Inc. (TSXV: ZCT) (OTCQB: ZCTFF) (FSE: 9L2) (the "Company" or…

10 months ago

Zero Candida Commences Trading on OTCQB Market

VANCOUVER, BC, March 12, 2025 /PRNewswire/ -- Zero Candida Technologies, Inc. (TSXV: ZCT) (OTCQB: ZCTFF) (FSE: 9L2) (the "Company" or…

10 months ago

Advarra Unveils Oncology Research Pulse

Content-Driven Program Brings Together Clinical Trial Stakeholders to Foster Knowledge Sharing and Collaboration in Cancer Research COLUMBIA, Md., March 12,…

10 months ago

Advarra Unveils Oncology Research Pulse

Content-Driven Program Brings Together Clinical Trial Stakeholders to Foster Knowledge Sharing and Collaboration in Cancer Research COLUMBIA, Md., March 12,…

10 months ago

Remedy Cell and Qureight collaborate to integrate deep learning platform into Phase 1b study of RC-0315 in IPF

HAIFA, Israel, and CAMBRIDGE, England, March 12, 2025 /PRNewswire/ -- Remedy Cell, a clinical-stage biopharmaceutical company focused on the development of…

10 months ago

Remedy Cell and Qureight collaborate to integrate deep learning platform into Phase 1b study of RC-0315 in IPF

HAIFA, Israel, and CAMBRIDGE, England, March 12, 2025 /PRNewswire/ -- Remedy Cell, a clinical-stage biopharmaceutical company focused on the development of…

10 months ago